GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cosmo Bio Co Ltd (TSE:3386) » Definitions » Total Liabilities

Cosmo Bio Co (TSE:3386) Total Liabilities : 円1,847 Mil (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Cosmo Bio Co Total Liabilities?

Cosmo Bio Co's Total Liabilities for the quarter that ended in Dec. 2023 was 円1,847 Mil.

Cosmo Bio Co's quarterly Total Liabilities increased from Jun. 2023 (円1,764.00 Mil) to Sep. 2023 (円1,774.00 Mil) and increased from Sep. 2023 (円1,774.00 Mil) to Dec. 2023 (円1,847.00 Mil).

Cosmo Bio Co's annual Total Liabilities declined from Dec. 2021 (円1,755.00 Mil) to Dec. 2022 (円1,696.00 Mil) but then increased from Dec. 2022 (円1,696.00 Mil) to Dec. 2023 (円1,847.00 Mil).


Cosmo Bio Co Total Liabilities Historical Data

The historical data trend for Cosmo Bio Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Bio Co Total Liabilities Chart

Cosmo Bio Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,571.00 1,780.00 1,755.00 1,696.00 1,847.00

Cosmo Bio Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,696.00 1,867.00 1,764.00 1,774.00 1,847.00

Cosmo Bio Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cosmo Bio Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1123+(0+169
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+555)
=1,847

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=10872-9025
=1,847

Cosmo Bio Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1123+(0+169
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+555)
=1,847

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=10872-9025
=1,847

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosmo Bio Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cosmo Bio Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmo Bio Co (TSE:3386) Business Description

Traded in Other Exchanges
N/A
Address
2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes purchase of reagents, instruments, clinical test drugs for research on life science and domestic sales.

Cosmo Bio Co (TSE:3386) Headlines

No Headlines